nodes	percent_of_prediction	percent_of_DWPC	metapath
Drospirenone—AR—Fluoxymesterone—breast cancer	0.136	0.859	CbGbCtD
Drospirenone—PGR—breast cancer	0.114	0.355	CbGaD
Drospirenone—AR—breast cancer	0.0935	0.291	CbGaD
Drospirenone—BCHE—breast cancer	0.0781	0.243	CbGaD
Drospirenone—Formestane—Exemestane—breast cancer	0.0401	0.119	CrCrCtD
Drospirenone—PTGS2—breast cancer	0.036	0.112	CbGaD
Drospirenone—Eplerenone—Fluoxymesterone—breast cancer	0.0332	0.0983	CrCrCtD
Drospirenone—Potassium Canrenoate—Fluoxymesterone—breast cancer	0.0251	0.0744	CrCrCtD
Drospirenone—Spironolactone—Fluoxymesterone—breast cancer	0.0251	0.0744	CrCrCtD
Drospirenone—Testolactone—Exemestane—breast cancer	0.025	0.0742	CrCrCtD
Drospirenone—Megestrol acetate—Fluoxymesterone—breast cancer	0.023	0.0681	CrCrCtD
Drospirenone—BCHE—Irinotecan—breast cancer	0.0223	0.141	CbGbCtD
Drospirenone—Medroxyprogesterone Acetate—Fluoxymesterone—breast cancer	0.0204	0.0606	CrCrCtD
Drospirenone—Testosterone—Exemestane—breast cancer	0.0195	0.0576	CrCrCtD
Drospirenone—Norethindrone—Fluoxymesterone—breast cancer	0.0184	0.0547	CrCrCtD
Drospirenone—Cortisone acetate—Fluoxymesterone—breast cancer	0.0179	0.053	CrCrCtD
Drospirenone—Testolactone—Fluoxymesterone—breast cancer	0.0173	0.0514	CrCrCtD
Drospirenone—Progesterone—Fluoxymesterone—breast cancer	0.0155	0.046	CrCrCtD
Drospirenone—Testosterone Propionate—Fluoxymesterone—breast cancer	0.0155	0.046	CrCrCtD
Drospirenone—Methyltestosterone—Fluoxymesterone—breast cancer	0.0151	0.0449	CrCrCtD
Drospirenone—Testosterone—Fluoxymesterone—breast cancer	0.0135	0.04	CrCrCtD
Drospirenone—Hydrocortisone—Fluoxymesterone—breast cancer	0.0127	0.0375	CrCrCtD
Drospirenone—PGR—corpus luteum—breast cancer	0.00632	0.231	CbGeAlD
Drospirenone—PGR—mammary gland—breast cancer	0.000979	0.0359	CbGeAlD
Drospirenone—NR3C2—nipple—breast cancer	0.000871	0.0319	CbGeAlD
Drospirenone—PGR—nipple—breast cancer	0.00081	0.0297	CbGeAlD
Drospirenone—AR—nipple—breast cancer	0.000645	0.0236	CbGeAlD
Drospirenone—PGR—epithelium—breast cancer	0.000545	0.02	CbGeAlD
Drospirenone—NR3C2—endometrium—breast cancer	0.000526	0.0193	CbGeAlD
Drospirenone—BCHE—nipple—breast cancer	0.000525	0.0192	CbGeAlD
Drospirenone—PGR—endometrium—breast cancer	0.000489	0.0179	CbGeAlD
Drospirenone—NR3C2—uterus—breast cancer	0.000485	0.0178	CbGeAlD
Drospirenone—NR3C2—pituitary gland—breast cancer	0.000476	0.0174	CbGeAlD
Drospirenone—NR3C2—adipose tissue—breast cancer	0.000474	0.0174	CbGeAlD
Drospirenone—PGR—uterus—breast cancer	0.000451	0.0165	CbGeAlD
Drospirenone—PGR—pituitary gland—breast cancer	0.000443	0.0162	CbGeAlD
Drospirenone—PGR—adipose tissue—breast cancer	0.000441	0.0161	CbGeAlD
Drospirenone—NR3C2—female reproductive system—breast cancer	0.000436	0.016	CbGeAlD
Drospirenone—AR—epithelium—breast cancer	0.000434	0.0159	CbGeAlD
Drospirenone—NR3C2—adrenal gland—breast cancer	0.000425	0.0156	CbGeAlD
Drospirenone—AR—skin of body—breast cancer	0.000413	0.0151	CbGeAlD
Drospirenone—PGR—female reproductive system—breast cancer	0.000405	0.0148	CbGeAlD
Drospirenone—NR3C2—female gonad—breast cancer	0.000397	0.0145	CbGeAlD
Drospirenone—PGR—adrenal gland—breast cancer	0.000395	0.0145	CbGeAlD
Drospirenone—AR—endometrium—breast cancer	0.00039	0.0143	CbGeAlD
Drospirenone—NR3C2—endocrine gland—breast cancer	0.000369	0.0135	CbGeAlD
Drospirenone—PGR—female gonad—breast cancer	0.000369	0.0135	CbGeAlD
Drospirenone—AR—uterus—breast cancer	0.000359	0.0131	CbGeAlD
Drospirenone—AR—pituitary gland—breast cancer	0.000353	0.0129	CbGeAlD
Drospirenone—AR—adipose tissue—breast cancer	0.000351	0.0129	CbGeAlD
Drospirenone—PGR—endocrine gland—breast cancer	0.000343	0.0126	CbGeAlD
Drospirenone—BCHE—skin of body—breast cancer	0.000336	0.0123	CbGeAlD
Drospirenone—PTGS2—embryo—breast cancer	0.000334	0.0122	CbGeAlD
Drospirenone—AR—female reproductive system—breast cancer	0.000323	0.0118	CbGeAlD
Drospirenone—BCHE—endometrium—breast cancer	0.000317	0.0116	CbGeAlD
Drospirenone—AR—adrenal gland—breast cancer	0.000315	0.0115	CbGeAlD
Drospirenone—AR—female gonad—breast cancer	0.000294	0.0108	CbGeAlD
Drospirenone—BCHE—uterus—breast cancer	0.000292	0.0107	CbGeAlD
Drospirenone—BCHE—pituitary gland—breast cancer	0.000287	0.0105	CbGeAlD
Drospirenone—BCHE—adipose tissue—breast cancer	0.000286	0.0105	CbGeAlD
Drospirenone—AR—endocrine gland—breast cancer	0.000273	0.01	CbGeAlD
Drospirenone—PTGS2—epithelium—breast cancer	0.000272	0.00997	CbGeAlD
Drospirenone—BCHE—female reproductive system—breast cancer	0.000263	0.00962	CbGeAlD
Drospirenone—PTGS2—skin of body—breast cancer	0.000259	0.00949	CbGeAlD
Drospirenone—BCHE—adrenal gland—breast cancer	0.000256	0.00938	CbGeAlD
Drospirenone—NR3C2—lymph node—breast cancer	0.000255	0.00934	CbGeAlD
Drospirenone—BCHE—bone marrow—breast cancer	0.000248	0.00908	CbGeAlD
Drospirenone—PTGS2—endometrium—breast cancer	0.000244	0.00894	CbGeAlD
Drospirenone—PGR—lymph node—breast cancer	0.000237	0.00868	CbGeAlD
Drospirenone—Haemoglobin—Anastrozole—breast cancer	0.000233	0.00262	CcSEcCtD
Drospirenone—Erythema multiforme—Ixabepilone—breast cancer	0.000232	0.00262	CcSEcCtD
Drospirenone—Embolism—Capecitabine—breast cancer	0.000232	0.00261	CcSEcCtD
Drospirenone—Haemorrhage—Anastrozole—breast cancer	0.000231	0.00261	CcSEcCtD
Drospirenone—Haemorrhage—Letrozole—breast cancer	0.000231	0.00261	CcSEcCtD
Drospirenone—Mental disorder—Exemestane—breast cancer	0.000228	0.00257	CcSEcCtD
Drospirenone—Nervous system disorder—Lapatinib—breast cancer	0.000227	0.00256	CcSEcCtD
Drospirenone—Skin disorder—Lapatinib—breast cancer	0.000225	0.00253	CcSEcCtD
Drospirenone—PTGS2—uterus—breast cancer	0.000225	0.00824	CbGeAlD
Drospirenone—Cerebrovascular accident—Goserelin—breast cancer	0.000223	0.00251	CcSEcCtD
Drospirenone—Angiopathy—Ixabepilone—breast cancer	0.000223	0.00251	CcSEcCtD
Drospirenone—BCHE—endocrine gland—breast cancer	0.000222	0.00814	CbGeAlD
Drospirenone—PTGS2—pituitary gland—breast cancer	0.000221	0.00809	CbGeAlD
Drospirenone—Haemoglobin—Idarubicin—breast cancer	0.000221	0.00249	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Fulvestrant—breast cancer	0.000221	0.00249	CcSEcCtD
Drospirenone—PTGS2—adipose tissue—breast cancer	0.00022	0.00806	CbGeAlD
Drospirenone—Haemorrhage—Idarubicin—breast cancer	0.00022	0.00247	CcSEcCtD
Drospirenone—Erythema multiforme—Letrozole—breast cancer	0.000219	0.00246	CcSEcCtD
Drospirenone—Erythema multiforme—Anastrozole—breast cancer	0.000219	0.00246	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Toremifene—breast cancer	0.000218	0.00245	CcSEcCtD
Drospirenone—Mood swings—Tamoxifen—breast cancer	0.000217	0.00244	CcSEcCtD
Drospirenone—Mental disorder—Ixabepilone—breast cancer	0.000215	0.00242	CcSEcCtD
Drospirenone—Migraine—Goserelin—breast cancer	0.000215	0.00242	CcSEcCtD
Drospirenone—Affect lability—Goserelin—breast cancer	0.000215	0.00242	CcSEcCtD
Drospirenone—Thrombosis—Capecitabine—breast cancer	0.00021	0.00237	CcSEcCtD
Drospirenone—Angiopathy—Letrozole—breast cancer	0.00021	0.00236	CcSEcCtD
Drospirenone—Nervous system disorder—Fulvestrant—breast cancer	0.000209	0.00235	CcSEcCtD
Drospirenone—Breast pain—Paclitaxel—breast cancer	0.000208	0.00234	CcSEcCtD
Drospirenone—Mood swings—Goserelin—breast cancer	0.000207	0.00233	CcSEcCtD
Drospirenone—Skin disorder—Fulvestrant—breast cancer	0.000207	0.00233	CcSEcCtD
Drospirenone—Nervous system disorder—Toremifene—breast cancer	0.000206	0.00232	CcSEcCtD
Drospirenone—Embolism venous—Epirubicin—breast cancer	0.000206	0.00232	CcSEcCtD
Drospirenone—Skin disorder—Toremifene—breast cancer	0.000204	0.0023	CcSEcCtD
Drospirenone—Mental disorder—Letrozole—breast cancer	0.000203	0.00228	CcSEcCtD
Drospirenone—PTGS2—female reproductive system—breast cancer	0.000202	0.00741	CbGeAlD
Drospirenone—Gastrointestinal disorder—Lapatinib—breast cancer	0.0002	0.00225	CcSEcCtD
Drospirenone—Cerebrovascular accident—Vinorelbine—breast cancer	0.0002	0.00225	CcSEcCtD
Drospirenone—Angiopathy—Idarubicin—breast cancer	0.000199	0.00224	CcSEcCtD
Drospirenone—Angiopathy—Raloxifene—breast cancer	0.000199	0.00224	CcSEcCtD
Drospirenone—Breast disorder—Goserelin—breast cancer	0.000198	0.00223	CcSEcCtD
Drospirenone—PTGS2—adrenal gland—breast cancer	0.000197	0.00723	CbGeAlD
Drospirenone—Nausea—Fluoxymesterone—breast cancer	0.000194	0.00218	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Exemestane—breast cancer	0.000192	0.00216	CcSEcCtD
Drospirenone—PTGS2—bone marrow—breast cancer	0.000191	0.00699	CbGeAlD
Drospirenone—Embolism venous—Doxorubicin—breast cancer	0.00019	0.00214	CcSEcCtD
Drospirenone—AR—lymph node—breast cancer	0.000189	0.00691	CbGeAlD
Drospirenone—PTGS2—female gonad—breast cancer	0.000184	0.00674	CbGeAlD
Drospirenone—Gastrointestinal disorder—Fulvestrant—breast cancer	0.000184	0.00207	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Toremifene—breast cancer	0.000182	0.00204	CcSEcCtD
Drospirenone—Nervous system disorder—Exemestane—breast cancer	0.000182	0.00204	CcSEcCtD
Drospirenone—Depression—Vinblastine—breast cancer	0.000181	0.00204	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Ixabepilone—breast cancer	0.000181	0.00204	CcSEcCtD
Drospirenone—Skin disorder—Exemestane—breast cancer	0.00018	0.00202	CcSEcCtD
Drospirenone—Acute coronary syndrome—Vinblastine—breast cancer	0.000179	0.00202	CcSEcCtD
Drospirenone—Myocardial infarction—Vinblastine—breast cancer	0.000178	0.002	CcSEcCtD
Drospirenone—Depression—Tamoxifen—breast cancer	0.000176	0.00198	CcSEcCtD
Drospirenone—Acute coronary syndrome—Tamoxifen—breast cancer	0.000174	0.00196	CcSEcCtD
Drospirenone—Myocardial infarction—Tamoxifen—breast cancer	0.000173	0.00195	CcSEcCtD
Drospirenone—Embolism—Methotrexate—breast cancer	0.000173	0.00194	CcSEcCtD
Drospirenone—Nervous system disorder—Ixabepilone—breast cancer	0.000171	0.00193	CcSEcCtD
Drospirenone—PTGS2—endocrine gland—breast cancer	0.000171	0.00627	CbGeAlD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Letrozole—breast cancer	0.00017	0.00192	CcSEcCtD
Drospirenone—Skin disorder—Ixabepilone—breast cancer	0.00017	0.00191	CcSEcCtD
Drospirenone—Erythema multiforme—Chlorambucil—breast cancer	0.000168	0.00189	CcSEcCtD
Drospirenone—Depression—Goserelin—breast cancer	0.000168	0.00189	CcSEcCtD
Drospirenone—Acute coronary syndrome—Goserelin—breast cancer	0.000166	0.00187	CcSEcCtD
Drospirenone—Myocardial infarction—Goserelin—breast cancer	0.000165	0.00186	CcSEcCtD
Drospirenone—Cerebrovascular accident—Irinotecan—breast cancer	0.000165	0.00186	CcSEcCtD
Drospirenone—Haemoglobin—Vinblastine—breast cancer	0.000164	0.00185	CcSEcCtD
Drospirenone—Haemorrhage—Vinblastine—breast cancer	0.000163	0.00184	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Idarubicin—breast cancer	0.000162	0.00182	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Raloxifene—breast cancer	0.000162	0.00182	CcSEcCtD
Drospirenone—Embolism—Epirubicin—breast cancer	0.000162	0.00182	CcSEcCtD
Drospirenone—Nervous system disorder—Letrozole—breast cancer	0.000161	0.00182	CcSEcCtD
Drospirenone—Cerebrovascular accident—Gemcitabine—breast cancer	0.000161	0.00181	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Exemestane—breast cancer	0.00016	0.0018	CcSEcCtD
Drospirenone—Skin disorder—Letrozole—breast cancer	0.00016	0.0018	CcSEcCtD
Drospirenone—Haemoglobin—Tamoxifen—breast cancer	0.000159	0.00179	CcSEcCtD
Drospirenone—Haemorrhage—Tamoxifen—breast cancer	0.000158	0.00178	CcSEcCtD
Drospirenone—Haemoglobin—Melphalan—breast cancer	0.000156	0.00176	CcSEcCtD
Drospirenone—Haemorrhage—Melphalan—breast cancer	0.000155	0.00175	CcSEcCtD
Drospirenone—BCHE—lymph node—breast cancer	0.000154	0.00563	CbGeAlD
Drospirenone—Nervous system disorder—Raloxifene—breast cancer	0.000153	0.00172	CcSEcCtD
Drospirenone—Haemoglobin—Goserelin—breast cancer	0.000152	0.00171	CcSEcCtD
Drospirenone—Skin disorder—Raloxifene—breast cancer	0.000152	0.00171	CcSEcCtD
Drospirenone—Skin disorder—Idarubicin—breast cancer	0.000152	0.00171	CcSEcCtD
Drospirenone—Haemorrhage—Goserelin—breast cancer	0.000151	0.0017	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Ixabepilone—breast cancer	0.000151	0.0017	CcSEcCtD
Drospirenone—Erythema multiforme—Tamoxifen—breast cancer	0.00015	0.00169	CcSEcCtD
Drospirenone—Embolism—Doxorubicin—breast cancer	0.00015	0.00168	CcSEcCtD
Drospirenone—Acute coronary syndrome—Vinorelbine—breast cancer	0.000149	0.00168	CcSEcCtD
Drospirenone—Megestrol acetate—PGR—breast cancer	0.000149	0.0557	CrCbGaD
Drospirenone—Myocardial infarction—Vinorelbine—breast cancer	0.000148	0.00167	CcSEcCtD
Drospirenone—Testosterone Propionate—CYP17A1—breast cancer	0.000147	0.055	CrCbGaD
Drospirenone—Thrombosis—Epirubicin—breast cancer	0.000147	0.00165	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Letrozole—breast cancer	0.000142	0.0016	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Anastrozole—breast cancer	0.000142	0.0016	CcSEcCtD
Drospirenone—Nausea—Lapatinib—breast cancer	0.000138	0.00155	CcSEcCtD
Drospirenone—Testolactone—CYP19A1—breast cancer	0.000137	0.0515	CrCbGaD
Drospirenone—Angiopathy—Goserelin—breast cancer	0.000137	0.00155	CcSEcCtD
Drospirenone—Thrombosis—Doxorubicin—breast cancer	0.000136	0.00153	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Raloxifene—breast cancer	0.000135	0.00152	CcSEcCtD
Drospirenone—Cerebrovascular accident—Paclitaxel—breast cancer	0.000134	0.00151	CcSEcCtD
Drospirenone—Mental disorder—Goserelin—breast cancer	0.000133	0.00149	CcSEcCtD
Drospirenone—Haemoglobin—Thiotepa—breast cancer	0.00013	0.00146	CcSEcCtD
Drospirenone—Haemorrhage—Thiotepa—breast cancer	0.000129	0.00146	CcSEcCtD
Drospirenone—Nausea—Fulvestrant—breast cancer	0.000127	0.00143	CcSEcCtD
Drospirenone—Nausea—Toremifene—breast cancer	0.000125	0.00141	CcSEcCtD
Drospirenone—Mood swings—Paclitaxel—breast cancer	0.000125	0.00141	CcSEcCtD
Drospirenone—Angiopathy—Vinorelbine—breast cancer	0.000123	0.00138	CcSEcCtD
Drospirenone—Acute coronary syndrome—Mitoxantrone—breast cancer	0.000123	0.00138	CcSEcCtD
Drospirenone—Acute coronary syndrome—Irinotecan—breast cancer	0.000123	0.00138	CcSEcCtD
Drospirenone—Myocardial infarction—Mitoxantrone—breast cancer	0.000122	0.00137	CcSEcCtD
Drospirenone—Myocardial infarction—Irinotecan—breast cancer	0.000122	0.00137	CcSEcCtD
Drospirenone—Testosterone Propionate—COMT—breast cancer	0.00012	0.0448	CrCbGaD
Drospirenone—Acute coronary syndrome—Gemcitabine—breast cancer	0.00012	0.00135	CcSEcCtD
Drospirenone—Breast disorder—Paclitaxel—breast cancer	0.000119	0.00134	CcSEcCtD
Drospirenone—Breast pain—Epirubicin—breast cancer	0.000119	0.00134	CcSEcCtD
Drospirenone—Myocardial infarction—Gemcitabine—breast cancer	0.000119	0.00134	CcSEcCtD
Drospirenone—PTGS2—lymph node—breast cancer	0.000118	0.00433	CbGeAlD
Drospirenone—Acute coronary syndrome—Fluorouracil—breast cancer	0.000118	0.00132	CcSEcCtD
Drospirenone—Angiopathy—Thiotepa—breast cancer	0.000117	0.00132	CcSEcCtD
Drospirenone—Myocardial infarction—Fluorouracil—breast cancer	0.000117	0.00132	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Melphalan—breast cancer	0.000114	0.00129	CcSEcCtD
Drospirenone—Mental disorder—Thiotepa—breast cancer	0.000113	0.00128	CcSEcCtD
Drospirenone—Haemoglobin—Mitoxantrone—breast cancer	0.000112	0.00126	CcSEcCtD
Drospirenone—Haemoglobin—Irinotecan—breast cancer	0.000112	0.00126	CcSEcCtD
Drospirenone—Haemorrhage—Irinotecan—breast cancer	0.000112	0.00126	CcSEcCtD
Drospirenone—Haemorrhage—Mitoxantrone—breast cancer	0.000112	0.00126	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Goserelin—breast cancer	0.000111	0.00125	CcSEcCtD
Drospirenone—Cerebrovascular accident—Capecitabine—breast cancer	0.00011	0.00124	CcSEcCtD
Drospirenone—Breast pain—Doxorubicin—breast cancer	0.00011	0.00124	CcSEcCtD
Drospirenone—Nausea—Exemestane—breast cancer	0.00011	0.00124	CcSEcCtD
Drospirenone—Migraine—Docetaxel—breast cancer	0.00011	0.00124	CcSEcCtD
Drospirenone—Haemoglobin—Gemcitabine—breast cancer	0.000109	0.00123	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Chlorambucil—breast cancer	0.000109	0.00123	CcSEcCtD
Drospirenone—Haemorrhage—Gemcitabine—breast cancer	0.000109	0.00123	CcSEcCtD
Drospirenone—Haemoglobin—Fluorouracil—breast cancer	0.000108	0.00121	CcSEcCtD
Drospirenone—Haemorrhage—Fluorouracil—breast cancer	0.000107	0.00121	CcSEcCtD
Drospirenone—Skin disorder—Melphalan—breast cancer	0.000107	0.00121	CcSEcCtD
Drospirenone—Migraine—Capecitabine—breast cancer	0.000106	0.0012	CcSEcCtD
Drospirenone—Nervous system disorder—Goserelin—breast cancer	0.000105	0.00119	CcSEcCtD
Drospirenone—Skin disorder—Goserelin—breast cancer	0.000104	0.00118	CcSEcCtD
Drospirenone—Nausea—Ixabepilone—breast cancer	0.000104	0.00117	CcSEcCtD
Drospirenone—Erythema multiforme—Gemcitabine—breast cancer	0.000103	0.00116	CcSEcCtD
Drospirenone—Mood swings—Capecitabine—breast cancer	0.000102	0.00115	CcSEcCtD
Drospirenone—Angiopathy—Irinotecan—breast cancer	0.000101	0.00114	CcSEcCtD
Drospirenone—Depression—Paclitaxel—breast cancer	0.000101	0.00114	CcSEcCtD
Drospirenone—Breast disorder—Docetaxel—breast cancer	0.000101	0.00114	CcSEcCtD
Drospirenone—Acute coronary syndrome—Paclitaxel—breast cancer	0.0001	0.00113	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—breast cancer	9.97e-05	0.00112	CcSEcCtD
Drospirenone—Myocardial infarction—Paclitaxel—breast cancer	9.95e-05	0.00112	CcSEcCtD
Drospirenone—Angiopathy—Gemcitabine—breast cancer	9.88e-05	0.00111	CcSEcCtD
Drospirenone—Breast disorder—Capecitabine—breast cancer	9.77e-05	0.0011	CcSEcCtD
Drospirenone—Nausea—Letrozole—breast cancer	9.77e-05	0.0011	CcSEcCtD
Drospirenone—Nausea—Anastrozole—breast cancer	9.77e-05	0.0011	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Tamoxifen—breast cancer	9.72e-05	0.00109	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—breast cancer	9.53e-05	0.00107	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Melphalan—breast cancer	9.51e-05	0.00107	CcSEcCtD
Drospirenone—Nervous system disorder—Vinorelbine—breast cancer	9.44e-05	0.00106	CcSEcCtD
Drospirenone—Skin disorder—Vinorelbine—breast cancer	9.35e-05	0.00105	CcSEcCtD
Drospirenone—Nausea—Raloxifene—breast cancer	9.27e-05	0.00104	CcSEcCtD
Drospirenone—Nausea—Idarubicin—breast cancer	9.27e-05	0.00104	CcSEcCtD
Drospirenone—Spironolactone—PGR—breast cancer	9.23e-05	0.0346	CrCbGaD
Drospirenone—Haemoglobin—Paclitaxel—breast cancer	9.16e-05	0.00103	CcSEcCtD
Drospirenone—Haemorrhage—Paclitaxel—breast cancer	9.12e-05	0.00103	CcSEcCtD
Drospirenone—Nervous system disorder—Thiotepa—breast cancer	9.02e-05	0.00102	CcSEcCtD
Drospirenone—Skin disorder—Thiotepa—breast cancer	8.93e-05	0.00101	CcSEcCtD
Drospirenone—Testosterone Propionate—AR—breast cancer	8.92e-05	0.0334	CrCbGaD
Drospirenone—Medroxyprogesterone Acetate—PGR—breast cancer	8.65e-05	0.0324	CrCbGaD
Drospirenone—Spironolactone—SHBG—breast cancer	8.63e-05	0.0323	CrCbGaD
Drospirenone—Erythema multiforme—Paclitaxel—breast cancer	8.62e-05	0.00097	CcSEcCtD
Drospirenone—Norethindrone—PGR—breast cancer	8.58e-05	0.0321	CrCbGaD
Drospirenone—Acute coronary syndrome—Docetaxel—breast cancer	8.48e-05	0.000955	CcSEcCtD
Drospirenone—Myocardial infarction—Docetaxel—breast cancer	8.44e-05	0.00095	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Vinorelbine—breast cancer	8.31e-05	0.000936	CcSEcCtD
Drospirenone—Depression—Capecitabine—breast cancer	8.31e-05	0.000935	CcSEcCtD
Drospirenone—Angiopathy—Paclitaxel—breast cancer	8.27e-05	0.000931	CcSEcCtD
Drospirenone—Acute coronary syndrome—Capecitabine—breast cancer	8.21e-05	0.000925	CcSEcCtD
Drospirenone—Cerebrovascular accident—Methotrexate—breast cancer	8.21e-05	0.000925	CcSEcCtD
Drospirenone—Myocardial infarction—Capecitabine—breast cancer	8.17e-05	0.00092	CcSEcCtD
Drospirenone—Medroxyprogesterone Acetate—SHBG—breast cancer	8.09e-05	0.0303	CrCbGaD
Drospirenone—Norethindrone—SHBG—breast cancer	8.01e-05	0.03	CrCbGaD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—breast cancer	8.01e-05	0.000902	CcSEcCtD
Drospirenone—Mental disorder—Paclitaxel—breast cancer	7.99e-05	0.000899	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Thiotepa—breast cancer	7.94e-05	0.000894	CcSEcCtD
Drospirenone—Nervous system disorder—Irinotecan—breast cancer	7.79e-05	0.000877	CcSEcCtD
Drospirenone—Haemoglobin—Docetaxel—breast cancer	7.77e-05	0.000874	CcSEcCtD
Drospirenone—Haemorrhage—Docetaxel—breast cancer	7.73e-05	0.00087	CcSEcCtD
Drospirenone—Skin disorder—Mitoxantrone—breast cancer	7.71e-05	0.000868	CcSEcCtD
Drospirenone—Cerebrovascular accident—Epirubicin—breast cancer	7.69e-05	0.000865	CcSEcCtD
Drospirenone—Mood swings—Methotrexate—breast cancer	7.63e-05	0.000859	CcSEcCtD
Drospirenone—Methyltestosterone—SHBG—breast cancer	7.61e-05	0.0285	CrCbGaD
Drospirenone—Nervous system disorder—Gemcitabine—breast cancer	7.59e-05	0.000854	CcSEcCtD
Drospirenone—Spironolactone—AR—breast cancer	7.57e-05	0.0284	CrCbGaD
Drospirenone—Haemoglobin—Capecitabine—breast cancer	7.52e-05	0.000846	CcSEcCtD
Drospirenone—Skin disorder—Gemcitabine—breast cancer	7.51e-05	0.000846	CcSEcCtD
Drospirenone—Nausea—Chlorambucil—breast cancer	7.51e-05	0.000846	CcSEcCtD
Drospirenone—Haemorrhage—Capecitabine—breast cancer	7.48e-05	0.000842	CcSEcCtD
Drospirenone—Nervous system disorder—Fluorouracil—breast cancer	7.46e-05	0.00084	CcSEcCtD
Drospirenone—Affect lability—Epirubicin—breast cancer	7.41e-05	0.000835	CcSEcCtD
Drospirenone—Migraine—Epirubicin—breast cancer	7.41e-05	0.000835	CcSEcCtD
Drospirenone—Erythema multiforme—Docetaxel—breast cancer	7.31e-05	0.000822	CcSEcCtD
Drospirenone—Breast disorder—Methotrexate—breast cancer	7.27e-05	0.000819	CcSEcCtD
Drospirenone—Mood swings—Epirubicin—breast cancer	7.14e-05	0.000803	CcSEcCtD
Drospirenone—Cerebrovascular accident—Doxorubicin—breast cancer	7.11e-05	0.000801	CcSEcCtD
Drospirenone—Medroxyprogesterone Acetate—AR—breast cancer	7.09e-05	0.0266	CrCbGaD
Drospirenone—Erythema multiforme—Capecitabine—breast cancer	7.07e-05	0.000796	CcSEcCtD
Drospirenone—Angiopathy—Docetaxel—breast cancer	7.01e-05	0.000789	CcSEcCtD
Drospirenone—Nausea—Vinblastine—breast cancer	6.88e-05	0.000775	CcSEcCtD
Drospirenone—Migraine—Doxorubicin—breast cancer	6.86e-05	0.000772	CcSEcCtD
Drospirenone—Affect lability—Doxorubicin—breast cancer	6.86e-05	0.000772	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Irinotecan—breast cancer	6.86e-05	0.000772	CcSEcCtD
Drospirenone—Breast disorder—Epirubicin—breast cancer	6.81e-05	0.000766	CcSEcCtD
Drospirenone—Angiopathy—Capecitabine—breast cancer	6.79e-05	0.000764	CcSEcCtD
Drospirenone—Mental disorder—Docetaxel—breast cancer	6.77e-05	0.000762	CcSEcCtD
Drospirenone—Progesterone—CYP17A1—breast cancer	6.74e-05	0.0252	CrCbGaD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	6.71e-05	0.000755	CcSEcCtD
Drospirenone—Nausea—Tamoxifen—breast cancer	6.69e-05	0.000753	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Gemcitabine—breast cancer	6.68e-05	0.000752	CcSEcCtD
Drospirenone—Methyltestosterone—AR—breast cancer	6.67e-05	0.025	CrCbGaD
Drospirenone—Mood swings—Doxorubicin—breast cancer	6.6e-05	0.000743	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Fluorouracil—breast cancer	6.57e-05	0.000739	CcSEcCtD
Drospirenone—Mental disorder—Capecitabine—breast cancer	6.55e-05	0.000738	CcSEcCtD
Drospirenone—Nausea—Melphalan—breast cancer	6.55e-05	0.000737	CcSEcCtD
Drospirenone—Nausea—Goserelin—breast cancer	6.39e-05	0.000719	CcSEcCtD
Drospirenone—Nervous system disorder—Paclitaxel—breast cancer	6.35e-05	0.000715	CcSEcCtD
Drospirenone—Breast disorder—Doxorubicin—breast cancer	6.3e-05	0.000709	CcSEcCtD
Drospirenone—Skin disorder—Paclitaxel—breast cancer	6.29e-05	0.000708	CcSEcCtD
Drospirenone—Depression—Methotrexate—breast cancer	6.19e-05	0.000696	CcSEcCtD
Drospirenone—Progesterone—ABCC1—breast cancer	6.11e-05	0.0229	CrCbGaD
Drospirenone—Hydrocortisone—SHBG—breast cancer	5.73e-05	0.0215	CrCbGaD
Drospirenone—Nausea—Vinorelbine—breast cancer	5.72e-05	0.000644	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	5.69e-05	0.00064	CcSEcCtD
Drospirenone—Haemoglobin—Methotrexate—breast cancer	5.6e-05	0.00063	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Paclitaxel—breast cancer	5.59e-05	0.000629	CcSEcCtD
Drospirenone—Methyltestosterone—CYP19A1—breast cancer	5.59e-05	0.0209	CrCbGaD
Drospirenone—Haemorrhage—Methotrexate—breast cancer	5.57e-05	0.000627	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	5.51e-05	0.00062	CcSEcCtD
Drospirenone—Medroxyprogesterone Acetate—ESR1—breast cancer	5.46e-05	0.0205	CrCbGaD
Drospirenone—Nausea—Thiotepa—breast cancer	5.46e-05	0.000615	CcSEcCtD
Drospirenone—Nervous system disorder—Docetaxel—breast cancer	5.38e-05	0.000606	CcSEcCtD
Drospirenone—Skin disorder—Docetaxel—breast cancer	5.33e-05	0.0006	CcSEcCtD
Drospirenone—Erythema multiforme—Methotrexate—breast cancer	5.27e-05	0.000593	CcSEcCtD
Drospirenone—Haemoglobin—Epirubicin—breast cancer	5.24e-05	0.00059	CcSEcCtD
Drospirenone—Nervous system disorder—Capecitabine—breast cancer	5.21e-05	0.000587	CcSEcCtD
Drospirenone—Haemorrhage—Epirubicin—breast cancer	5.21e-05	0.000587	CcSEcCtD
Drospirenone—Skin disorder—Capecitabine—breast cancer	5.16e-05	0.000581	CcSEcCtD
Drospirenone—Angiopathy—Methotrexate—breast cancer	5.05e-05	0.000569	CcSEcCtD
Drospirenone—Progesterone—PGR—breast cancer	5e-05	0.0187	CrCbGaD
Drospirenone—Cortisone acetate—CYP3A4—breast cancer	4.96e-05	0.0186	CrCbGaD
Drospirenone—Erythema multiforme—Epirubicin—breast cancer	4.93e-05	0.000555	CcSEcCtD
Drospirenone—Mental disorder—Methotrexate—breast cancer	4.88e-05	0.000549	CcSEcCtD
Drospirenone—Haemoglobin—Doxorubicin—breast cancer	4.85e-05	0.000546	CcSEcCtD
Drospirenone—Haemorrhage—Doxorubicin—breast cancer	4.82e-05	0.000543	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Docetaxel—breast cancer	4.74e-05	0.000534	CcSEcCtD
Drospirenone—Angiopathy—Epirubicin—breast cancer	4.73e-05	0.000532	CcSEcCtD
Drospirenone—Nausea—Irinotecan—breast cancer	4.72e-05	0.000531	CcSEcCtD
Drospirenone—Nausea—Mitoxantrone—breast cancer	4.72e-05	0.000531	CcSEcCtD
Drospirenone—Progesterone—SHBG—breast cancer	4.67e-05	0.0175	CrCbGaD
Drospirenone—Progesterone—CYP1B1—breast cancer	4.67e-05	0.0175	CrCbGaD
Drospirenone—Nausea—Gemcitabine—breast cancer	4.59e-05	0.000517	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Capecitabine—breast cancer	4.59e-05	0.000517	CcSEcCtD
Drospirenone—Mental disorder—Epirubicin—breast cancer	4.57e-05	0.000514	CcSEcCtD
Drospirenone—Erythema multiforme—Doxorubicin—breast cancer	4.56e-05	0.000513	CcSEcCtD
Drospirenone—Nausea—Fluorouracil—breast cancer	4.52e-05	0.000509	CcSEcCtD
Drospirenone—Testosterone—SHBG—breast cancer	4.42e-05	0.0165	CrCbGaD
Drospirenone—Testosterone—CYP1B1—breast cancer	4.42e-05	0.0165	CrCbGaD
Drospirenone—Angiopathy—Doxorubicin—breast cancer	4.37e-05	0.000493	CcSEcCtD
Drospirenone—Eplerenone—CYP3A4—breast cancer	4.36e-05	0.0163	CrCbGaD
Drospirenone—Mental disorder—Doxorubicin—breast cancer	4.22e-05	0.000476	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	4.1e-05	0.000461	CcSEcCtD
Drospirenone—Progesterone—AR—breast cancer	4.1e-05	0.0153	CrCbGaD
Drospirenone—Megestrol acetate—ABCB1—breast cancer	3.98e-05	0.0149	CrCbGaD
Drospirenone—Hydrocortisone—ABCG2—breast cancer	3.95e-05	0.0148	CrCbGaD
Drospirenone—Nervous system disorder—Methotrexate—breast cancer	3.88e-05	0.000437	CcSEcCtD
Drospirenone—Testosterone—AR—breast cancer	3.87e-05	0.0145	CrCbGaD
Drospirenone—Nausea—Paclitaxel—breast cancer	3.85e-05	0.000433	CcSEcCtD
Drospirenone—Skin disorder—Methotrexate—breast cancer	3.84e-05	0.000433	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	3.84e-05	0.000432	CcSEcCtD
Drospirenone—Nervous system disorder—Epirubicin—breast cancer	3.63e-05	0.000409	CcSEcCtD
Drospirenone—Skin disorder—Epirubicin—breast cancer	3.6e-05	0.000405	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	3.55e-05	0.0004	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Methotrexate—breast cancer	3.42e-05	0.000385	CcSEcCtD
Drospirenone—Nervous system disorder—Doxorubicin—breast cancer	3.36e-05	0.000378	CcSEcCtD
Drospirenone—Skin disorder—Doxorubicin—breast cancer	3.33e-05	0.000375	CcSEcCtD
Drospirenone—Nausea—Docetaxel—breast cancer	3.26e-05	0.000367	CcSEcCtD
Drospirenone—Testosterone—CYP19A1—breast cancer	3.24e-05	0.0121	CrCbGaD
Drospirenone—Gastrointestinal disorder—Epirubicin—breast cancer	3.2e-05	0.00036	CcSEcCtD
Drospirenone—Nausea—Capecitabine—breast cancer	3.16e-05	0.000355	CcSEcCtD
Drospirenone—Progesterone—ESR1—breast cancer	3.15e-05	0.0118	CrCbGaD
Drospirenone—Testosterone—ABCG2—breast cancer	3.04e-05	0.0114	CrCbGaD
Drospirenone—Gastrointestinal disorder—Doxorubicin—breast cancer	2.96e-05	0.000333	CcSEcCtD
Drospirenone—Medroxyprogesterone Acetate—CYP3A4—breast cancer	2.79e-05	0.0104	CrCbGaD
Drospirenone—Norethindrone—CYP3A4—breast cancer	2.76e-05	0.0104	CrCbGaD
Drospirenone—Methyltestosterone—CYP3A4—breast cancer	2.62e-05	0.00983	CrCbGaD
Drospirenone—Progesterone—CYP1A1—breast cancer	2.52e-05	0.00945	CrCbGaD
Drospirenone—Spironolactone—ABCB1—breast cancer	2.48e-05	0.00928	CrCbGaD
Drospirenone—Norethindrone—ALB—breast cancer	2.41e-05	0.00903	CrCbGaD
Drospirenone—Testosterone—CYP1A1—breast cancer	2.38e-05	0.00893	CrCbGaD
Drospirenone—Nausea—Methotrexate—breast cancer	2.35e-05	0.000265	CcSEcCtD
Drospirenone—Norethindrone—ABCB1—breast cancer	2.3e-05	0.00862	CrCbGaD
Drospirenone—Methyltestosterone—ALB—breast cancer	2.29e-05	0.00858	CrCbGaD
Drospirenone—Nausea—Epirubicin—breast cancer	2.2e-05	0.000248	CcSEcCtD
Drospirenone—Nausea—Doxorubicin—breast cancer	2.03e-05	0.000229	CcSEcCtD
Drospirenone—Hydrocortisone—CYP3A4—breast cancer	1.98e-05	0.0074	CrCbGaD
Drospirenone—Progesterone—CYP2D6—breast cancer	1.88e-05	0.00703	CrCbGaD
Drospirenone—Hydrocortisone—ABCB1—breast cancer	1.65e-05	0.00616	CrCbGaD
Drospirenone—Progesterone—CYP3A4—breast cancer	1.61e-05	0.00603	CrCbGaD
Drospirenone—Testosterone—CYP3A4—breast cancer	1.52e-05	0.0057	CrCbGaD
Drospirenone—Progesterone—ABCB1—breast cancer	1.34e-05	0.00502	CrCbGaD
Drospirenone—Testosterone—ALB—breast cancer	1.33e-05	0.00497	CrCbGaD
Drospirenone—Testosterone—ABCB1—breast cancer	1.27e-05	0.00475	CrCbGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	5.5e-06	8.66e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—WNT1—breast cancer	5.48e-06	8.64e-05	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—MAPK3—breast cancer	5.48e-06	8.64e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—NAT2—breast cancer	5.48e-06	8.64e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SLC2A2—breast cancer	5.45e-06	8.58e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—FASN—breast cancer	5.4e-06	8.51e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MTR—breast cancer	5.34e-06	8.41e-05	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—MYC—breast cancer	5.33e-06	8.4e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SMAD4—breast cancer	5.32e-06	8.39e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—SLC5A5—breast cancer	5.31e-06	8.37e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IGF1R—breast cancer	5.29e-06	8.34e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HES1—breast cancer	5.2e-06	8.19e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—IGF1—breast cancer	5.19e-06	8.17e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NCOR1—breast cancer	5.17e-06	8.14e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PLA2G4A—breast cancer	5.17e-06	8.14e-05	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—MYC—breast cancer	5.14e-06	8.1e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—NQO1—breast cancer	5.13e-06	8.08e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—SLC2A1—breast cancer	5.13e-06	8.08e-05	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—SERPINE1—breast cancer	5.13e-06	8.08e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CSF2—breast cancer	5.11e-06	8.05e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FGF1—breast cancer	5.11e-06	8.05e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NRG1—breast cancer	5.07e-06	7.99e-05	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	5.05e-06	7.95e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—H2AFX—breast cancer	5.04e-06	7.93e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	5.02e-06	7.92e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—MMP2—breast cancer	5.02e-06	7.91e-05	CbGpPWpGaD
Drospirenone—BCHE—Neuronal System—HRAS—breast cancer	5.01e-06	7.9e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CYP3A4—breast cancer	5e-06	7.88e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—E2F1—breast cancer	5e-06	7.88e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	4.98e-06	7.84e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HSPA1B—breast cancer	4.96e-06	7.81e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	4.96e-06	7.81e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CYP1B1—breast cancer	4.92e-06	7.75e-05	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	4.88e-06	7.7e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—HSP90AA1—breast cancer	4.82e-06	7.6e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—DPYD—breast cancer	4.81e-06	7.57e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—MED12—breast cancer	4.81e-06	7.57e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SPP1—breast cancer	4.8e-06	7.57e-05	CbGpPWpGaD
Drospirenone—AR—Gene Expression—ESR1—breast cancer	4.76e-06	7.49e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ENO1—breast cancer	4.76e-06	7.49e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ERBB3—breast cancer	4.75e-06	7.49e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FGFR2—breast cancer	4.74e-06	7.47e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ALDOA—breast cancer	4.73e-06	7.45e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—NCOA1—breast cancer	4.69e-06	7.39e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—STK11—breast cancer	4.63e-06	7.29e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CYP19A1—breast cancer	4.63e-06	7.29e-05	CbGpPWpGaD
Drospirenone—AR—Gene Expression—NOTCH1—breast cancer	4.6e-06	7.24e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—NCOA3—breast cancer	4.59e-06	7.24e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—SLC2A2—breast cancer	4.56e-06	7.19e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TERT—breast cancer	4.55e-06	7.17e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	4.51e-06	7.11e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—FGF3—breast cancer	4.5e-06	7.08e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CPT1A—breast cancer	4.47e-06	7.04e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—MTR—breast cancer	4.47e-06	7.04e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ABCG2—breast cancer	4.47e-06	7.04e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—FASN—breast cancer	4.44e-06	6.99e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—JAG1—breast cancer	4.44e-06	6.99e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FGFR1—breast cancer	4.42e-06	6.97e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PARP1—breast cancer	4.42e-06	6.97e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—HPGDS—breast cancer	4.38e-06	6.9e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CALCA—breast cancer	4.37e-06	6.88e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HIF1A—breast cancer	4.36e-06	6.86e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—HBA1—breast cancer	4.35e-06	6.86e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PTEN—breast cancer	4.34e-06	6.84e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—RPS6—breast cancer	4.31e-06	6.8e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—COMT—breast cancer	4.3e-06	6.77e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—FGF4—breast cancer	4.28e-06	6.75e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GSTP1—breast cancer	4.28e-06	6.74e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CXCR4—breast cancer	4.27e-06	6.72e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—LEP—breast cancer	4.25e-06	6.7e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ACHE—breast cancer	4.25e-06	6.7e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GSTT1—breast cancer	4.25e-06	6.7e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—HMOX1—breast cancer	4.22e-06	6.65e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SLC2A1—breast cancer	4.22e-06	6.64e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CAV1—breast cancer	4.21e-06	6.64e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ITPR1—breast cancer	4.21e-06	6.63e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—CXCL8—breast cancer	4.17e-06	6.57e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—KDR—breast cancer	4.17e-06	6.56e-05	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	4.12e-06	6.5e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—TCF7L2—breast cancer	4.11e-06	6.48e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ESR1—breast cancer	4.06e-06	6.39e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ABCB1—breast cancer	4.05e-06	6.38e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP17A1—breast cancer	4.02e-06	6.34e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FN1—breast cancer	4.01e-06	6.32e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ENO1—breast cancer	3.98e-06	6.27e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PTGS1—breast cancer	3.98e-06	6.27e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—TYMS—breast cancer	3.98e-06	6.27e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	3.97e-06	6.25e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HSP90AA1—breast cancer	3.97e-06	6.25e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NFKBIA—breast cancer	3.96e-06	6.24e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—NCOR1—breast cancer	3.93e-06	6.2e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GSTM1—breast cancer	3.93e-06	6.2e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PLA2G4A—breast cancer	3.93e-06	6.2e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NOTCH1—breast cancer	3.92e-06	6.18e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—ALB—breast cancer	3.92e-06	6.17e-05	CbGpPWpGaD
Drospirenone—AR—Gene Expression—SERPINE1—breast cancer	3.91e-06	6.16e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP2D6—breast cancer	3.91e-06	6.15e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PRL—breast cancer	3.86e-06	6.08e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—CTNNB1—breast cancer	3.85e-06	6.06e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PIK3CG—breast cancer	3.84e-06	6.05e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—KIT—breast cancer	3.84e-06	6.05e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—APC—breast cancer	3.84e-06	6.05e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—NCOA2—breast cancer	3.83e-06	6.04e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ADAM10—breast cancer	3.8e-06	5.99e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—EGF—breast cancer	3.79e-06	5.98e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GPX1—breast cancer	3.77e-06	5.93e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CYP1A1—breast cancer	3.73e-06	5.87e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—FASN—breast cancer	3.72e-06	5.86e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—BCHE—breast cancer	3.7e-06	5.83e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—FGF10—breast cancer	3.7e-06	5.83e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ERCC2—breast cancer	3.7e-06	5.83e-05	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—AKT1—breast cancer	3.7e-06	5.83e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—SLC5A5—breast cancer	3.66e-06	5.76e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—BRAF—breast cancer	3.61e-06	5.68e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PDGFA—breast cancer	3.57e-06	5.62e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—SLC2A1—breast cancer	3.53e-06	5.56e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—NQO1—breast cancer	3.53e-06	5.56e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—TGFBR2—breast cancer	3.52e-06	5.54e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IGF1—breast cancer	3.51e-06	5.53e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—AKT2—breast cancer	3.51e-06	5.53e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—MTHFR—breast cancer	3.48e-06	5.48e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ITPR1—breast cancer	3.46e-06	5.45e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.46e-06	5.45e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP3A4—breast cancer	3.44e-06	5.43e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ERBB4—breast cancer	3.44e-06	5.42e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—STAT5A—breast cancer	3.44e-06	5.42e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP1B1—breast cancer	3.39e-06	5.33e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PIK3CD—breast cancer	3.37e-06	5.31e-05	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—MAPK3—breast cancer	3.34e-06	5.26e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SERPINE1—breast cancer	3.34e-06	5.26e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SMAD4—breast cancer	3.33e-06	5.25e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—HSP90AA1—breast cancer	3.32e-06	5.23e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HES1—breast cancer	3.25e-06	5.12e-05	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—MYC—breast cancer	3.25e-06	5.12e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NCOR1—breast cancer	3.23e-06	5.09e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—NCOA1—breast cancer	3.23e-06	5.09e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CAV1—breast cancer	3.21e-06	5.05e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—FGF1—breast cancer	3.2e-06	5.04e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NOS3—breast cancer	3.19e-06	5.02e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—STK11—breast cancer	3.18e-06	5.02e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP19A1—breast cancer	3.18e-06	5.02e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NRG1—breast cancer	3.17e-06	5e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—H2AFX—breast cancer	3.15e-06	4.96e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.06e-06	4.83e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ERCC2—breast cancer	3.04e-06	4.79e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MDM2—breast cancer	3.02e-06	4.76e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—RAF1—breast cancer	3.01e-06	4.74e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—RELA—breast cancer	3e-06	4.72e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.99e-06	4.71e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ERBB2—breast cancer	2.98e-06	4.69e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ERBB3—breast cancer	2.97e-06	4.68e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—FGFR2—breast cancer	2.97e-06	4.68e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—COMT—breast cancer	2.96e-06	4.66e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GSTP1—breast cancer	2.95e-06	4.64e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MTOR—breast cancer	2.94e-06	4.63e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PIK3CB—breast cancer	2.94e-06	4.63e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PIK3CG—breast cancer	2.92e-06	4.6e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—HMOX1—breast cancer	2.91e-06	4.58e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ITPR1—breast cancer	2.9e-06	4.57e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MTHFR—breast cancer	2.86e-06	4.5e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—TERT—breast cancer	2.85e-06	4.49e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CXCL8—breast cancer	2.83e-06	4.45e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ABCB1—breast cancer	2.79e-06	4.39e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—FGFR1—breast cancer	2.77e-06	4.36e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CDKN1B—breast cancer	2.76e-06	4.35e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—TYMS—breast cancer	2.74e-06	4.31e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HIF1A—breast cancer	2.72e-06	4.29e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—NCOR1—breast cancer	2.71e-06	4.26e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PLA2G4A—breast cancer	2.71e-06	4.26e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GSTM1—breast cancer	2.71e-06	4.26e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CASP3—breast cancer	2.7e-06	4.26e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IL2—breast cancer	2.7e-06	4.25e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CAV1—breast cancer	2.64e-06	4.15e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCND1—breast cancer	2.63e-06	4.15e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—JUN—breast cancer	2.63e-06	4.14e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CTNNB1—breast cancer	2.61e-06	4.11e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GPX1—breast cancer	2.59e-06	4.08e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PIK3CD—breast cancer	2.57e-06	4.04e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP1A1—breast cancer	2.57e-06	4.04e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MMP9—breast cancer	2.56e-06	4.03e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CDKN1A—breast cancer	2.55e-06	4.01e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ERCC2—breast cancer	2.55e-06	4.01e-05	CbGpPWpGaD
Drospirenone—AR—Gene Expression—MAPK3—breast cancer	2.54e-06	4.01e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PTEN—breast cancer	2.54e-06	4e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ALB—breast cancer	2.53e-06	3.99e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MAPK8—breast cancer	2.49e-06	3.92e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NOS2—breast cancer	2.48e-06	3.9e-05	CbGpPWpGaD
Drospirenone—AR—Gene Expression—MYC—breast cancer	2.47e-06	3.9e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NOTCH1—breast cancer	2.45e-06	3.87e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—NOS3—breast cancer	2.42e-06	3.82e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—KIT—breast cancer	2.4e-06	3.78e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—APC—breast cancer	2.4e-06	3.78e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—MTHFR—breast cancer	2.39e-06	3.77e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—EGF—breast cancer	2.37e-06	3.74e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SRC—breast cancer	2.36e-06	3.71e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—VEGFA—breast cancer	2.29e-06	3.62e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—STAT3—breast cancer	2.27e-06	3.58e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—BRAF—breast cancer	2.26e-06	3.55e-05	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—AKT1—breast cancer	2.25e-06	3.55e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PIK3CB—breast cancer	2.24e-06	3.53e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PTGS2—breast cancer	2.22e-06	3.49e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CAV1—breast cancer	2.21e-06	3.48e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—AKT2—breast cancer	2.2e-06	3.46e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MAPK3—breast cancer	2.17e-06	3.42e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MYC—breast cancer	2.11e-06	3.33e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PIK3CD—breast cancer	2.11e-06	3.32e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.11e-06	3.32e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TGFB1—breast cancer	2.11e-06	3.32e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SERPINE1—breast cancer	2.09e-06	3.29e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—EGFR—breast cancer	2.07e-06	3.25e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PIK3CG—breast cancer	2.01e-06	3.17e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NOS3—breast cancer	1.99e-06	3.14e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—KRAS—breast cancer	1.95e-06	3.07e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PTEN—breast cancer	1.93e-06	3.05e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MDM2—breast cancer	1.89e-06	2.98e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—RAF1—breast cancer	1.88e-06	2.97e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ERBB2—breast cancer	1.86e-06	2.94e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MTOR—breast cancer	1.84e-06	2.9e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PIK3CB—breast cancer	1.84e-06	2.9e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CD4—breast cancer	1.84e-06	2.89e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PIK3CA—breast cancer	1.79e-06	2.82e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PIK3CD—breast cancer	1.77e-06	2.78e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ALB—breast cancer	1.74e-06	2.75e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TP53—breast cancer	1.73e-06	2.73e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CDKN1B—breast cancer	1.73e-06	2.72e-05	CbGpPWpGaD
Drospirenone—AR—Gene Expression—AKT1—breast cancer	1.72e-06	2.7e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—NOS3—breast cancer	1.67e-06	2.63e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HRAS—breast cancer	1.66e-06	2.61e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CTNNB1—breast cancer	1.63e-06	2.57e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CDKN1A—breast cancer	1.59e-06	2.51e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PTEN—breast cancer	1.59e-06	2.5e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IL6—breast cancer	1.59e-06	2.5e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PIK3CB—breast cancer	1.54e-06	2.43e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SRC—breast cancer	1.47e-06	2.32e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—AKT1—breast cancer	1.46e-06	2.31e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—STAT3—breast cancer	1.42e-06	2.24e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PIK3CA—breast cancer	1.36e-06	2.15e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MAPK3—breast cancer	1.36e-06	2.14e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PTEN—breast cancer	1.33e-06	2.1e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MYC—breast cancer	1.32e-06	2.08e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—TGFB1—breast cancer	1.32e-06	2.08e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—EGFR—breast cancer	1.29e-06	2.04e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—KRAS—breast cancer	1.22e-06	1.92e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PIK3CA—breast cancer	1.12e-06	1.77e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—AKT1—breast cancer	1.11e-06	1.76e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HRAS—breast cancer	1.04e-06	1.63e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—IL6—breast cancer	9.93e-07	1.56e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PIK3CA—breast cancer	9.39e-07	1.48e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—AKT1—breast cancer	9.16e-07	1.44e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—AKT1—breast cancer	7.67e-07	1.21e-05	CbGpPWpGaD
